Delivery Order SPE2DB24D2011-SPE2DB24FBPGC

Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,183.89 Firm Fixed Price Delivery Order is for the supply of the medication Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,578.00 firm fixed-price delivery order is for the supply of the drug Mounjaro 7.5 mg/0.5 ml pen (0.5 ml) to support DLA's medical programs. AmerisourceBergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,052 firm-fixed-price delivery order is for the medication Mounjaro 7.5 mg/0.5 ml pen, with a completion date of November 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $4,273.17 firm fixed price delivery order is for the supply of the prescription medication Mounjaro 10 mg/0.5 ml pen. The contract has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This federal contract award, valued at $1,904.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro 7.5 mg/0.5 ml pen, 0.5 ml, with a performance period ending on April 11, 2025. This delivery order is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,436.90 Firm Fixed Price delivery order is for the drug MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for...
This federal contract award, valued at $1,578.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The award is for the delivery of the prescription drug Mounjaro 7.5 mg/0.5 ml pen 0.5 ml. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, that serves as the primary vehicle for the company to provide pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,119.12, is for the provision of the pharmaceutical product Mounjaro 10 mg/0.5 ml pen with a completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,927.60 firm fixed-price delivery order is for the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a performance period ending on November 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,841.00, is for the delivery of the medication Mounjaro 7.5 mg/0.5 ml pen. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside contract. The company also holds an indefinite...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBPGC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical and healthcare distribution company Amerisourcebergen Corporation. The $1,098.08 firm fixed price delivery order is for the supply of the prescription medication Mounjaro 7.5 mg/0.5 ml pen.

Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order falls under that IDC. No set-aside designations were used for this contract.

Generated 7/5/24, 9:19 AM